NANOFIN

Investigational

Details

Stereochemistry	UNKNOWN
Molecular Formula	C7H15N
Molecular Weight	113.2007
Optical Activity	UNSPECIFIED
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC1CCCC(C)N1

InChI

InChIKey=SDGKUVSVPIIUCF-UHFFFAOYSA-N

InChI=1S/C7H15N/c1-6-4-3-5-7(2)8-6/h6-8H,3-5H2,1-2H3

HIDE SMILES / InChI

Description

Nanofin is a ganglion blocker alkaloid having nicotinic acetylcholine receptor antagonist action. It has an antihypertensive effect used for mild to moderate hypertension. It was also used for the treatment of eczema and neurodermatitis.

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Nicotinic acetylcholine receptor	Antagonist

PubMed

Show entries

Title	Date	PubMed
Mechanism of hydrodenitrogenation on phosphides and sulfides.	2005 Feb 17	16851202
Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.	2009 Oct	19493592

Showing 1 to 2 of 2 entries

Previous1Next

Patents

Show entries

Name

Type

Language

NANOFIN

Official Name

English

nanofin [INN]

Common Name

English

NSC-63890

Code

English

2,6-LUPETIDINE

Systematic Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Anticholinergic Agent

NCI_THESAURUS

C66886

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

NCI_THESAURUS

C76789

PRIMARY

INN

1085

PRIMARY

PUBCHEM

68843

PRIMARY

NSC

63890

PRIMARY

SMS_ID

100000084465

PRIMARY

Showing 1 to 5 of 13 entries

Previous1 2 3Next

ACTIVE MOIETY


					329I5805BP

NANOFIN